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Abstract
Background: Ectopic fat accumulation in the renal sinus is associated with chronic kidney disease and
hypertension. The genetic contributions to renal sinus fat accumulation in humans have not been well
characterized.
Methods: The present analysis consists of participants from the Framingham Offspring and Third Generation who
underwent computed tomography; renal sinus fat and visceral adipose tissue (VAT) were quantified. Renal sinus fat
was natural log transformed and sex- and cohort-specific residuals were created, adjusted for (1) age, (2) age and
body mass index (BMI), and (3) age and VAT. Residuals were pooled and used to calculate heritability using
variance-components analysis in SOLAR. A genome-wide association study (GWAS) for renal sinus fat was
performed using an additive model with approximately 2.5 million imputed single nucleotide polymorphisms
(SNPs). Finally, we identified the associations of renal sinus fat in our GWAS results with validated SNPs for renal
function (n = 16), BMI (n = 32), and waist-to-hip ratio (WHR, n = 14), and applied a multi-SNP genetic risk score
method to determine if the SNPs for each renal and obesity trait were in aggregate associated with renal sinus fat.
Results: The heritability of renal sinus fat was 39% (p < 0.0001); results were not materially different after
adjustment for BMI (39%) or VAT (40%). No SNPs reached genome-wide significance in our GWAS. In our candidate
gene analysis, we observed nominal, direction consistent associations with renal sinus fat for one SNP associated
with renal function (p = 0.01), two associated with BMI (p < 0.03), and two associated with WHR (p < 0.03);
however, none remained significant after accounting for multiple testing. Finally, we observed that in aggregate,
the 32 SNPs associated with BMI were nominally associated with renal sinus fat (multi-SNP genetic risk score p =
0.03).
Conclusions: Renal sinus fat is a heritable trait, even after accounting for generalized and abdominal adiposity. This
provides support for further research into the genetic determinants of renal sinus fat. While our study was
underpowered to detect genome-wide significant loci, our candidate gene BMI risk score results suggest that
variability in renal sinus fat may be associated with SNPs previously known to be associated with generalized
adiposity.
Background
In the midst of a global obesity epidemic, current evi-
dence suggests that ectopic fat deposition, or fat accu-
mulation within and around non-adipose tissue and
organs [1], plays an important role in the development
of obesity-related disease and local organ dysfunction.
In the Framingham Heart Study, we have observed that
several ectopic fat depots are independently associated
with cardiometabolic risk above and beyond measures of
general obesity, including abdominal visceral adipose tis-
sue [2], pericardial fat [3], fatty liver [4], upper body
subcutaneous fat [5], and peri-aortic fat [6].
Obesity is also implicated in the development of
chronic kidney disease (CKD) [7-13], a common condi-
tion that affects over 13% of adults in the United States
[14]. In animal models, fat accumulation within the
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and renal function [1]. We have recently characterized
this novel ectopic fat depot in humans, and observed
that high renal sinus fat accumulation, or “fatty kidney,”
is associated with chronic kidney disease even after
accounting for other adiposity measures [15].
While the genetic components associated with ectopic
fat depots such as renal sinus fat have not been well stu-
died, a growing body of evidence supports the hypoth-
esis that an independent genetic contribution to ectopic
fat deposition exists beyond those implicated in general
obesity. Increased ectopic fat accumulation is a common
clinical characteristic that accompanies the loss of tradi-
tional adipose tissue stores in inherited lipodystrophies,
and several genetic loci are implicated in the pathogen-
esis of these disorders [16-18]. Measures of regional and
ectopic fat accumulation, including waist circumference
[19], waist-to-hip ratio (WHR) [20,21], and ectopic fat
in skeletal muscle [22], are heritable even after adjusting
for body mass index (BMI). Finally, several genetic loci
have also been identified in genome-wide association
studies (GWAS) that are associated with anthropometric
measures of regional, but not overall, obesity [23,24].
Thus, we sought to characterize the genetic contribu-
tion to renal sinus fat by assessing heritability and per-
forming a GWAS in the Framingham Heart Study. As
an ectopic fat depot that is associated with chronic kid-
ney disease, we also performed a candidate gene analysis
to assess the association of renal sinus fat with genetic
loci recently identified in association with renal function
[25] and adiposity measures [24,26].
Methods
Study sample
The study sample was comprised of participants from
the Framingham Heart Study Offspring and Third Gen-
eration cohorts who underwent multi-detector com-
puted tomography (MDCT) between 2002 and 2005.
T h eM D C Tp r o t o c o la n de l i g i b i l i t yc r i t e r i ah a v eb e e n
described previously [2]. Of the 3529 participants who
underwent MDCT, 2978 attended either the 7
th Off-
spring (1998-2001, N = 1259) or the 1
st Third Genera-
tion (2002-2005, N = 1719) examination and had an
MDCT scan interpretable for the renal sinus fat mea-
surement. Participants provided written informed con-
sent, and this study was approved by the institutional
review boards at the Boston University Medical Center
and Massachusetts General Hospital. In the heritability
analysis, participants without additional family members
in the sample were excluded in order to evaluate family
correlations, resulting in a sample size of 2946 partici-
pants (1489 women and 1457 men). For the GWAS and
candidate gene analysis, complete genotype data were
available for 2809 participants (1422 women, 1387 men).
Phenotype definition
Renal sinus fat (cm
2) was quantified in the right kidney
based on a single slice abdominal MDCT scan. In brief,
a representative slice of the renal sinus in the right kid-
ney was identified by the reader after identifying candi-
date slices based on visual inspection and applying a
selection rule. This measurement protocol has good
intra- and inter-reader reproducibility, with intra-class
correlation coefficients of 0.93 and 0.86, respectively
[27]. Different tissues appear in MDCT scans with
unique pixel densities in Hounsfield Units (HU), and
adipose tissue was identified based on a pixel density
ranging from -195 to -45 HU, centered on -120 HU.
Additional covariate assessment
Abdominal visceral adipose tissue volume (VAT, cm
3)
was assessed by abdominal MDCT, as previously
d e s c r i b e d[ 2 ] .A g ea n dB M I( k g / m
2) were determined
during the 7
th Offspring or 1
st Third Generation exam-
ination cycles. BMI was determined using weight and
height measurements obtained by trained clinic per-
sonnel. Obesity was defined as a BMI of at least 30 kg/
m
2. Hypertension was defined as a systolic blood pres-
sure ≥140 mmHg, a diastolic blood pressure ≥90
mmHg as measured based on the mean of two read-
ings by a clinic physician, or current use of hyperten-
sion medication. Chronic kidney disease was defined as
the presence of an estimated glomerular filtration rate
<6 0m L / m i n / 1 . 7 3m
2 based on the abbreviated Modi-
fication of Diet in Renal Disease Study Equation [28].
Diabetes was defined as the presence of a fasting
plasma glucose ≥126 mg/dL or current use of diabetes
medication.
Genotyping and Imputation
In the Framingham SNP Health Association Resource
(Genetics and Genomics Program, SHARe: SNP Health
Association Resource: http://public.nhlbi.nih.gov/Genet-
icsGenomics/home/share.aspx), approximately 550,000
single nucleotide polymorphisms (SNPs) were genotyped
with Affymetrix 500 K and 50 K gene-centric genotyp-
ing arrays (Affymetrix, Inc.; Santa Clara, CA). The geno-
typed SNPs and a reference panel based on the Phase II
C E UH a p M a pw e r et h e nu s e dt oc r e a t ea ni m p u t e ds e t
of approximately 2.5 million SNPs with MACH version
1.0.15 imputation software.
Statistical Analyses
Renal sinus fat (cm
2) was analyzed as a continuous trait
and, due to its skewed distribution, was natural log
transformed before residual creation. The lower limit of
detection was 0.0048 cm
2; renal sinus fat measurements
below 0.0048 cm
2 were set to 0.004 cm
2 before applying
the log transformation. Sex- and cohort-specific
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Page 2 of 8residuals for renal sinus fat were created, adjusted for
(1) age, (2) age and BMI, and (3) age and VAT.
Heritability of renal sinus fat in the total study sample
and separately among women and men was estimated in
SOLAR (Texas Biomedical Research Institute; San Anto-
nio, TX) using the residuals described above, with addi-
tive genetic variation calculated using variance-
components analysis. This measurement estimates the
proportion of the total variability in renal sinus fat attri-
butable to genotypic variability.
We performed our GWAS for continuous renal sinus
fat (sex- and cohort-specific residuals, adjusted for age
and BMI) using a linear mixed effects model to identify
additive genetic associations with our set of approxi-
mately 2.5 million imputed SNPs from Framingham
SHARe. We performed our linear mixed models using R
version 2.9.2 and the lmekin function in the GWAF
package and accounted for the correlation between
related individuals by including family specific random
effects with twice the kinship coefficient matrix as their
correlations, thus accounting for arbitrary pedigree
structures. A p-value of 5 × 10
-8 was used as the thresh-
old for genome-wide significance. In our GWAS results,
top independent SNPs were defined as SNPs with an r
2
<0 . 2w i t ho t h e rS N P si nag i v e ng e n o m i cr e g i o n( i . e .
when several SNPs r
2 > 0.20 were identified among our
top SNPs, the SNP with the lowest p-value was selected
to represent this genetic locus). We performed this ana-
lysis in the total sample as well as separately among
women and men. Given sex-based differences observed
for other regional fat depots [24], we also performed the
GWAS for renal sinus fat adjusted for age and BMI
among men and women separately. We identified the
top five SNPs in women and men separately and deter-
mined the beta coefficient and p-value for each SNP in
the opposite sex. All final results were filtered on low
imputation score (< 0.3) or minor allele frequency less
t h a n5 % .W ee s t i m a t et h a tw eh a v e8 0 - 9 0 %p o w e rt o
detect a 1.3% to 1.5% variation in our renal sinus fat
phenotype explained by a single SNP. In order to detect
variants that explain a similar variance in renal sinus fat
as for the strongest reported adiposity variant
(rs9939609 in the FTO gene, explaining about 1% of the
variance in BMI [29]) with 80-90% power, we estimate
that we would require a sample size of 3750 to 4400
individuals.
The candidate gene analysis was performed in the
overall sample based on our GWAS using age-adjusted
residuals. We investigated the association of renal
sinus fat with renal function and obesity-related SNPs
previously validated in large GWAS meta-analyses,
including SNPs known to be associated with renal
function (n = 16)[25], BMI (n = 32) [26], and WHR (n
= 14) [24]. We determined one-sided p-values to test
for direction-consistent associations for SNPs in this
analysis and then corrected for multiple testing by
applying a false-discovery rate (FDR) analysis and
determining the q-values as proposed by Storey and
Tibshirani [30]. The q-value can be interpreted as the
proportion of significant results that are false positives,
a n dw ec o n s i d e r e daq - v a l u e ≤0.05 as significant (i.e. at
this threshold, we expect that 5% of the observed sig-
nificant associations are false positives). The FDR ana-
lyses were performed using the ‘qvalue’ package [30] in
R version 2.9.2.
Finally, we used a multi-SNP genetic risk score
approach to determine if each set of SNPs associated
with (1) renal function (n = 16 SNPs), (2) BMI (n = 32
SNPs), or (3) WHR (n = 14 SNPs) were associated with
renal sinus fat. In brief, this method involves the crea-
tion of a risk score in our study sample based on linear
regression, with continuous renal sinus fat modeled
separately as a function of the three sets of SNPs above.
With this regression model, by assuming that the set of
SNPs used as explanatory variables are uncorrelated and
that a relatively small proportion of the variance in the
phenotype explained by these SNPs, we can use (1)
effect estimates for each SNP from the prior GWAS
analyses and (2) the effect estimates from out renal
sinus fat GWAS and (3) the standard errors for the
effect estimates for each SNP in our renal sinus fat
GWAS, to maximize the likelihood function and create
a summary test statistic across the candidate SNPs to
determine whether these SNPs in aggregate are asso-
ciated with renal sinus fat in our study sample. This test
statistic is distributed c2 with one degree of freedom,
and we determined whether this test statistic was signifi-
cant by comparing it to a critical value of
χ2
α=0.05,1df =3 . 8 4 . This method is a cross-phenotype
approach that allows us to identify potential enrichment
for the association of candidate genes with renal sinus
fat in our dataset and gives us an opportunity to
improve the power of our individual SNP approach.
Results
Study sample characteristics
Overall, the study sample consisted of 2978 participants
(50.8% women) with an average age of 51 years, average
B M Io f2 7 . 6k g / m
2, and a median renal sinus fat mea-
surement of 0.31 cm
2. Sex-specific characteristics of the
study sample are presented Table 1.
Heritability of renal sinus fat
The overall estimated heritability of renal sinus fat
adjusted for age was 39% (p < 0.0001, Table 2) and was
essentially unchanged after additional adjustment for
BMI (39%) or VAT (40%). The estimated heritability of
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55% in men (Table 2, all p < 0.0001).
GWAS of renal sinus fat
Results from the overall GWAS of renal sinus fat are
summarized in Figure 1. The quantile-quantile plot of
observed versus expected p-values (Figure 1a) suggests
that we did not observe p-values below 1 × 10
-8.A s
observed in the Manhattan plot (Figure 1b), no SNPs
reached genome-wide significance. The 20 top indepen-
dent SNPs are presented in Table 3, with p-values ran-
ging from 2.6 × 10
-5 to 1.2 × 10
-6.
Due to the sex-specific differences observed in regional
fat distribution GWAS [24], we performed our GWAS
among women and men separately. The quantile-quantile
plots in women and men are presented in Figures 2a and
2b, respectively. As observed in the Manhattan plots for
women (Figure 3a) and men (Figure 3b), no SNPs
reached the genome-wide significant threshold of 5 × 10
-
8. The top five independent SNPs in women and men are
presented in Table 4. To further assess potential sex-spe-
cific differences in associations, we performed a look-up
f o rt h et o pS N P sf r o mw o m e ni nt h eG W A Sr e s u l t si n
men and the top SNPs from men in the GWAS results in
women and observed all p ≥ 0.04 for the opposite sex.
Candidate gene analysis
Results from the candidate gene analyses of loci asso-
ciated with renal function, BMI, and WHR are pre-
sented in Tables S1, S2, and S3 (see Additional File 1).
Of the 16 independent renal function SNPs investigated,
we observed a nominal, direction-consistent association
with renal sinus fat at rs12917707 near UMOD (Addi-
tional File 1, Table S1, p = 0.01). This gene encodes the
renal tubular protein uromodulin, and we have pre-
viously observed that higher urinary uromodulin con-
centration is associated with an increased odds of
chronic kidney disease as well as with rs4293393, a
UMOD SNP in linkage disequilibrium with rs12917707
(r
2 = 1) [31]. For UMOD,t h em i n o rTa l l e l eo f
Table 1 Study sample characteristics by sex.
Women Men
n = 1512 n = 1466
Age (years) 52 ± 10 51 ± 11





Body Mass Index (kg/m
2) 27.0 ± 5.9 28.3 ± 4.6
Abdominal visceral adipose tissue
(cm
3)
1361 ± 836 2257 ± 1047
Obesity (%) 381 (25.2%) 409 (27.9%)
Hypertension (%) 405 (26.8%) 475 (32.4%)
Diabetes (%) 75 (5.0%) 100 (6.8%)
Chronic Kidney Disease (%) 60 (4.0%) 36 (2.5%)
Current Smoking (%) 188 (12.4%) 206 (14.1%)
Continuous characteristics are presented as mean ± standard deviation and
dichotomous characteristics are presented as N (%), unless otherwise noted.
* Renal sinus fat presented as median [25
th percentile, 75
th percentile]
Table 2 Estimated heritability (h
2) of renal sinus fat in the Framingham Offspring and Third Generation Cohorts
Whole Sample* Women* Men*









Age-adjusted** 0.39 0.04 0.47 0.08 0.51 0.08
Age-BMI adjusted** 0.39 0.04 0.44 0.08 0.49 0.08
Age-VAT adjusted** 0.40 0.04 0.43 0.08 0.55 0.08
Abbreviations: BMI = body mass index; VAT = abdominal visceral adipose tissue
* Whole sample N = 2946; women only sample N = 1489; men only sample N = 1457

















0  2  4  6 
Expected -log10P 
A 




















1  2  3 4 5  7  6 8  9  10  13  12  11 19  22  21  20  18  16  15  14 17 
Genetic Position by Chromosome 
X 
Figure 1 Renal sinus fat genome-wide association analysis
results in the overall sample. (a) Quantile-quantile plot for the
genome-wide association analysis of renal sinus fat, adjusted for
age, sex, and BMI. (b) Manhattan plot of results from the genome-
wide association analysis of renal sinus fat, adjusted for age, sex,
and BMI. The dotted line represents a -log p-value threshold of 5 ×
10
-8.
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estimated glomerular filtration rate and a lower odds of
chronic kidney disease [32]; similarly, we observed lower
renal sinus fat for this allele. Of the 32 independent
BMI SNPs investigated, we observed a nominal, direc-
tion-consistent association with renal sinus fat at
rs9816226 near ETV5 (Additional File 1, Table S2,p=
0.008), and at rs2287019 in QPCTL (p = 0.03). We
observed two direction-consistent SNPs associated with
WHR in CPEB4 (Additional File 1, Table S3,
rs6861681p = 0.02) and in ZNRF3 (rs4823006, p = 0.03).
However, upon further correction for multiple testing
by applying an FDR approach, none of the SNPs in the
candidate gene analysis achieved statistical significance
(q-values > 0.10).
Finally, we applied the multi-SNP risk score method
a n do b s e r v e dt h a tw h e nc o n s i d e r e di na g g r e g a t e ,t h e3 2
SNPs associated with BMI were nominally associated
with renal sinus fat (p = 0.03). In contrast, the set of 16
SNPs associated with renal function (p = 0.55) and the
s e to f1 4S N P sa s s o c i a t e dw i t hW H R( p=0 . 4 0 )w e r e
not associated with renal sinus fat.
Discussion
Renal sinus fat is a heritable trait in the Framingham
Heart Study, even after accounting for measures of gen-
eral and abdominal adiposity. No loci were uncovered in
association with renal sinus fat at the genome-wide sig-
nificant level and none of our individual SNPs derived
from recent GWAS analyses for renal function, BMI,
and WHR were associated with renal sinus fat after
accounting for multiple comparisons. However, our BMI
candidate SNP risk score test suggests that the 32 SNPs
associated with BMI are, in aggregate, associated with
renal sinus fat.
The heritability of renal sinus fat accumulation has
not been previously reported. Our estimated heritability
of renal sinus fat is consistent with heritability estimates












rs10744391 12 127890891 GLT1D1 A 0.29 0.67 1.2E-06 -0.224 (0.046)
rs580140 21 31739378 TIAM1 G 0.28 1.01 2.7E-06 -0.184
(0.039)
rs2282335 9 71055752 TJP2 A 0.36 0.98 3.6E-06 0.171
(0.037)
rs9375674 6 130258203 C6orf191 A 0.46 1.01 6.1E-06 0.158
(0.035)
rs1572050 13 93668766 GPC6 A 0.10 0.71 6.3E-06 -0.313 (0.069)
rs17736767 5 98607864 CHD1** G 0.27 0.74 6.6E-06 -0.208 (0.046)
rs12785341 11 109901068 ARHGAP20 C 0.09 0.91 8.3E-06 0.290 (0.065)
rs6686423 1 155704134 FCRL5 A 0.31 0.76 8.4E-06 -0.194 (0.044)
rs7311875 12 127859220 SLC15A4 G 0.29 1.01 1.0E-05 -0.169 (0.038)
rs907849 11 72001536 PDE2A G 0.23 0.91 1.2E-05 -0.190 (0.043)
rs2511864 11 82196824 PRCP C 0.12 0.97 1.3E-05 0.238 (0.055)
rs332479 3 315440 CHL1 C 0.46 1.01 1.6E-05 -0.150 (0.035)
rs3815053 17 32076589 MRM1 C 0.48 1.01 1.6E-05 -0.151 (0.035)
rs4529412 7 49243390 VWC2** T 0.19 0.98 2.1E-05 -0.192 (0.045)
rs1003136 5 127375714 SLC12A2** A 0.36 0.97 2.1E-05 -0.154 (0.036)
rs6426644 1 20907695 KIF17 C 0.36 1.01 2.1E-05 -0.154
(0.036)
rs31093 16 53923677 IRX6 G 0.35 1.00 2.2E-05 -0.157
(0.037)
rs9516371 13 93688375 GPC6 T 0.33 0.98 2.2E-05 -0.158
(0.037)
rs7325697 13 98915794 TM9SF2 T 0.16 0.99 2.3E-05 0.203
(0.048)
rs1543400 20 38896007 MAFB** C 0.50 0.97 2.6E-05 0.148
(0.035)
b coefficients for the association for sex- and cohort-specific residuals of natural log-transformed renal sinus fat, adjusted for age and BMI.
Nearby genes based on RefSeq genes (build 36). The gene is presented in boldface if the SNP is located within the gene.
* Independent SNPs defined as those with r
2 < 0.2 at any locus
** Closest reference gene > 60 Kb away
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ham Heart Study, which include estimates of 37-52% for
BMI [33], 41% for waist circumference [19], 36% for
abdominal VAT [2], and 57% for abdominal SAT. Our
results are notable for their persistence even after
accounting for body mass index or abdominal VAT,
suggesting that the observed proportion of the variance
in renal sinus fat attributable to genotypic variance is
not solely attributable to the correlation of renal sinus
fat with measures of generalized or abdominal adiposity.
Our findings extend the current literature related to the
heritability of adiposity traits and provide support for
further research into the genetic determinants of renal
sinus fat accumulation and, more generally, further
exploration of the genetic contributions to ectopic fat
accumulation beyond those attributed to overall or
abdominal adiposity.
Based on our heritability estimates, we performed a
GWAS to potentially identify novel loci associated with
renal sinus fat. While we did not observe any loci asso-
ciated with renal sinus fat at the genome-wide level of
significance, we acknowledge that our study was under-
powered to detect common genetic variants. The goal of
our candidate gene analysis was to identify SNPs that
may be jointly associated with renal sinus fat and renal
function or other measures of adiposity, which may pro-
vide insight into potential mechanisms relating localized
renal adiposity with renal function or overall regional fat
deposition patterns. However, none of our selected can-
didate SNPs was individually associated with renal sinus
fat after accounting for multiple testing. Of note, when
considered in aggregate, a risk score based on the com-
bined 32 BMI SNPs was nominally associated with renal
sinus fat, suggesting that our renal sinus fat GWAS
results are enriched with SNPs associated with BMI and
A
B
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Figure 3 Renal sinus fat Manhattan plots for the genome-wide
association analysis by sex. (a) Manhattan plot of results from the
genome-wide association analysis of renal sinus fat in women, adjusted
for age and BMI. The dotted line represents a -log p-value threshold of
5×1 0
-8. (b) Manhattan plot of results from the genome-wide
association analysis of renal sinus fat in men, adjusted for age and BMI.
The dotted line represents a -log p-value threshold of 5 × 10
-8.



































Figure 2 Renal sinus fat quantile-quantile plots for the genome-wide association analysis by sex. (a) Quantile-quantile plot for the
genome-wide association analysis of renal sinus fat in women, adjusted for age and BMI. (b) Quantile-quantile plot for the genome-wide
association analysis of renal sinus fat in men, adjusted for age and BMI.
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Page 6 of 8potentially that the biologic pathways implicated in
overall obesity based on these SNPs may also influence
ectopic fat accumulation in the renal sinus.
Strengths and Limitations
A strength of our study is our assessment of renal
sinus fat in a well-characterized community-based
sample of related individuals, allowing us to estimate
the heritability of renal sinus fat while adjusting for
the potential effects of general or abdominal adiposity.
There are limitations to our study that warrant men-
tion. Our study sample is predominately white, which
may limit the generalizability of our results to other
ethnic groups. Our measurement of renal sinus fat is
based on a single MDCT scan slice within the renal
sinus of the right kidney, which may lead to misclassi-
fication of renal sinus fat accumulation. We were
underpowered to detect modest associations that are
characteristic of adiposity-related SNPs [26]. Finally,
renal sinus fat is a novel ectopic fat depot that has not
been measured in other study samples. Thus, we were
unable to potentially combine our sample with other
cohorts in order to increase our sample size and
improve the power of our analyses.
Conclusions
Renal sinus fat is a heritable trait, even after accounting
for other measures of overall and abdominal adiposity.
While our study was underpowered to detect genome-
wide significant loci, our heritability estimates provide
support for further research into the genetic determi-
nants of renal sinus fat.
Additional material
Additional file 1: Additional file 1includes Supplemental Tables 1, 2,
and 3, presenting results from the candidate gene analyses of loci
associated with renal function, BMI, and the WHR.
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b P b P
rs2873333 2 236525509 CENTG2 C 0.43 0.69 -0.349 2.1E-07 0.069 0.17
rs17736767 5 98607864 CHD1 G 0.27 0.74 -0.340 2.3E-06 -0.080 0.14
rs17111435 11 109950861 ARHGAP20 G 0.08 1.00 0.462 2.6E-06 0.083 0.29
rs9375674 6 130258203 C6orf191 A 0.46 1.01 0.248 4.1E-06 0.087 0.04
rs2518144 12 8650712 AICDA T 0.45 0.98 0.253 4.1E-06 0.046 0.26












b P b P
rs2748531 14 23791741 TGM1 A 0.13 0.89 -0.299 3.6E-06 -0.126 0.14
rs13414916 2 159662666 TANC1 T 0.21 0.99 -0.231 5.4E-06 -0.082 0.23
rs11099681 4 149322904 NR3C2 C 0.27 1.01 0.207 5.8E-06 -0.053 0.39
rs12722875 1 116617007 ATP1A1 A 0.33 1.01 -0.190 1.3E-05 -0.005 0.93
rs12432394 14 21098781 OR10G3 T 0.20 0.78 -0.248 1.4E-05 -0.033 0.67
The b coefficients and p-values each of the top 5 SNPs in the opposite sex are presented in the far right columns.
b coefficients for the association separately in women and men for cohort-specific residuals of natural log-transformed renal sinus fat, adjusted for age and BMI.
Nearby genes based on RefSeq genes (build 36). The gene is presented in boldface if the SNP is located within the gene.
* Independent SNPs defined as those with r
2 < 0.2 at any locus
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